| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perspective Therapeutics, Inc. (CATX) has 8 insiders with recent SEC Form 4 filings, including 46 buys and 0 sells. CATX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 735.0K | $2.21M | - | |
| CFO | 600.0K | $1.80M | - | |
| Other | 150.0K | $450.0K | - | |
| Other | 90.0K | $270.0K | - | |
| Dir | 75.0K | $225.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2018 | Vitale Philip J | Director | Buy | 10,000 | $0.44 | $4,399.00 | +14.3% | |
| Mar 1, 2018 | Lavoy Thomas C | CEO And Chairman Of The Board | Buy | 50,000 | $0.44 | $21,958.14 | +9.3% | |
| Nov 24, 2017 | Austin Mark John | Controller/ Prin Fin&Acct Offic | Buy | 9,265 | $0.48 | $4,489.93 | +30.3% | |
| Nov 20, 2017 | Krachon Michael | VP Of Sales &Marketing | Buy | 55,000 | $0.50 | $27,373.82 | +9.4% | |
| Nov 16, 2017 | Vitale Philip J | Director | Buy | 30,000 | $0.44 | $13,236.13 | +3.8% | |
| Mar 10, 2017 | Lavoy Thomas C | CEO | Buy | 20,000 | $0.53 | $10,600.00 | +12.2% | |
| Jan 4, 2017 | Vitale Philip J | Director | Buy | 20,000 | $0.66 | $13,186.25 | +21.2% | |
| Dec 8, 2016 | Hoffmann Alan | Director | Buy | 20,000 | $0.57 | $11,400.00 | New | |
| Nov 17, 2016 | Lavoy Thomas C | CEO | Buy | 20,000 | $0.60 | $12,000.00 | +13.9% | |
| Mar 17, 2016 | Lavoy Thomas C | CEO | Buy | 13,294 | $0.90 | $11,964.60 | +10.2% |